ÂÜÀòÂÒÂ×

Svetlana Lucas has extensive experience in the biotechnology and pharmaceutical industries, currently serving as a Board Member at Jasper Therapeutics and aTyr Pharma, and as an Advisor at Radar Therapeutics. Svetlana is also the Chief Business Officer at Scribe Therapeutics and has held senior roles in business development, including SVP at Tizona Therapeutics, Executive Director at Amgen, and Director positions at Onyx Pharmaceuticals and XOMA. With a Ph.D. in Biochemistry & Molecular Biology from Caltech and a Diplom in Virology & Molecular Biology from Lomonosov Moscow State University, Svetlana brings a strong scientific and business acumen to their leadership roles.